Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention
Conclusions/interpretationD. welbionis abundance is
influenced by metformin treatment and associated with prebiotic response, liver
health and glucose metabolism in humans with obesity and diabetes. This study
suggests thatD. welbionis may play a role in
metabolic health and warrants further investigation.Clinical trialNCT03852069Graphical Abstract
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Type 2 | Diets | Eating Disorders & Weight Management | Endocrinology | Fortamet | Liver | Metformin | Nutrition | Obesity | Study | Urology & Nephrology